Chronic impairment of the vagus nerve function leads to inhibition of dopamine but not serotonin neurons in rat brain structures

Pharmacological Reports

Volumn 64, Issue 6, 2012, Pages 1359-1367

  Ziomber, Agata ^a   Thor, Piotr ^a   Krygowska Wajs, Anna ^a   Załȩcki, Tomasz ^b   Moskała, Marek ^a   Romańska, Irena ^c   Michaluk, Jerzy ^c   Antkiewicz Michaluk, Lucyna ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Department of Neurology   (Poland)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Brain structures; Dopamine metabolism; Electrical stimulation; Rat; Serotonin metabolism; Vagus nerve

Indexed keywords

DOPAMINE; SEROTONIN;

ABDOMINAL WALL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CHROMATOGRAPHY; CONTROLLED STUDY; DOPAMINE METABOLISM; ELECTROCHEMICAL DETECTION; EX VIVO STUDY; IMPLANTATION; MALE; MICROCHIP ANALYSIS; NERVE CELL; NEUROCHEMISTRY; NEUROMUSCULAR ELECTRICAL STIMULATION; NONHUMAN; PATHOLOGICAL ANATOMY; RAT; SEROTONIN METABOLISM; VAGOTOMY; VAGUS NERVE INJURY;

EID: 84873736086     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70933-7     Document Type: Article

References (38)

1. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A et al.: Frequency of bowel movements and the future risk of Parkinson's disease. Neurology, 2001, 57, 456-462. (Pubitemid 32757593)
2. Antkiewicz-Michaluk L, Michaluk J, Mokrosz M, Romańska I, Lorenc-Koci E, Ohta S, Vetulani J: Different action on dopamine catabolism pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties. J Neurochem, 2001, 78, 100-108. (Pubitemid 32622592)
3. Ben-Menachem E: Vagus nerve stimulation for the treatment of epilepsy. Lancet Neurology, 2002, 1, 477-482.
4. Bugajski AJ, Gil K, Ziomber A, Zurowski D, Zaraska W, Thor PJ: Effect of long-term vagal stimulation on food intake and body weight during diet induced obesity in rats. J Physiol Pharmacol, 2007, 58, Suppl 1, 5-12. (Pubitemid 350022255)
5. Braak H, Del Tredici K, Rüb U, De Vos RAI, Ernst NH, Steur J, Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 2003, 24, 197-211. (Pubitemid 36007810)
6. Castell JA, Johnston BT, Colcher A, Li Q, Gideon RM, Castell DO: Manometric abnormalities of the oesophagus in patients with Parkinson's disease. Neurogastroenterol Motil, 2001, 13, 361-364. (Pubitemid 32953672)
7. DiBona GF, Kopp UC: Neural control of renal function. Physiol Rev, 1997, 77, 75-197.
8. Edwards L, Quigley EMM, Hofman R, Pfeiffer RF: Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology. Mov Disord, 1993, 8, 83-86.
9. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE: Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Behav, 2000, 1, 203-210.
10. Fukunishi I, Hosokawa K, Ozaki S: Depression antedating the onset of Parkinson's disease. Jpn J Psychiatry Neurol, 1991, 45, 7-11.
11. Friedman A, Potulska A: Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin. Parkins Relat Disord, 2001, 1, 329-332.
12. Gai WP, Blumbergs PC, Geffen LB, Blessing WW: Age-related loss of dorsal vagal neurons in Parkinson's disease. Neurology, 1992, 42, 2106-2111.
13. Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST: Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology, 2002, 58, 1247-1255. (Pubitemid 34411870)
14. Guze BH, Barrio JC: The etiology of depression in Parkinson's disease patients. Psychosomatics, 1991, 32, 390-395.
15. Kallio M, Haapaniemi T, Turkka J, Suominen K, Tolonen U, Sotaniemi K, Heikkila VP, Myllyla V: Heart rate variability in patients with untreated Parkinson's disease. Eur J Neurol, 2000, 7, 667-672. (Pubitemid 32154398)
16. 15O blood flow imaging. Neurosurgery,1996, 39, 426-430.
17. Kostić VS, Lesić D, Doder M, Marinković J, Filipowić S: Prolactin and cortisol responses to fenfluramine in Parkinson's disease. Biol Psychiatry, 1996, 40, 769-775.
18. Kuter K, Kolasiewicz W, Gołembiowska K, Dziubina A, Schulze G, Berghauze K, Wardas J, Ossowska K: Pharmacol Rep, 2011, 63, 1383-1392.
19. Langston JW: The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol, 2006, 59, 591-596.
20. Laskiewicz J, Królczyk G, Zurowski D, Enck P, Thor PJ: Capasaicin induced deafferentation enhances the effect of electrical vagal nerve stimulation on food intake and body mass. J Physiol Pharmacol, 2004, 55, 155-163. (Pubitemid 38450983)
21. Laskiewicz J, Królczyk G, Zurowski D, Sobocki J, Matyja A, Thor PJ: Effects of vagal neuromodulation and vagotomy on control of food intake and body weight in rats. J Physiol Pharmacol, 2003, 54, 603-610. (Pubitemid 38035114)
22. Lin MT, Tsay BL, Chen FF: Activation of dopaminergic receptors within the caudate-putamen complex facilitates reflex bradycardia in the rat. Jpn J Physiol, 1982, 32, 4231-4442.
23. Lin MT, Yang JJ: Stimulation of the nigrostriatal dopamine system produces hypertension and tachycardia. Am J Physiol, 1994, 266, H2489-H2496.
24. Lyons KE, Pahwa R: The impact and management of nonmotor symptoms of Parkinson's disease. Am J Manag Care, 2011, 17, Suppl, 12, S308-314.
25. Martignoni E, Pacchetti C, Godi L, Micieli G, Nappi G: Autonomic disorders in Parkinson's disease. J Neural Transm, 1995, 45, Suppl, 11-19.
26. McLachlan RS: Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia, 1993, 34, 918-923.
27. Mellers JD, Quinn NP, Ron MA: Psychotic and depressive symptoms in Parkinson's disease. A study of the growth hormone response to apomorphine. Br J Psychiatry, 1995, 167, 522-526. (Pubitemid 26194156)
28. Pazo JH, Belforte JE: Basal ganglia and functions of the autonomic nervous system. Cell Mol Neurobiol, 2002, 22, 645-648.
29. Polak T, Weise D, Metzger F, Ehlis AC, Langer JB, Schramm A, Fallgatter AJ, Classen J: Vagus nerve somatosensory evoked potentials in Parkinson's disease. J Neurol, 2011, 258, 2276-2277.
30. Porter RW, Bors E: Neurogenic bladder in Parkinsonism; effect of thalamotomy. J Neurosurg, 1971, 34, 27-32.
31. Raedt R, Clinckers R, Mollet L, Vonck K, Tahry RE, Wyckhuys T, Herdt VD et al.: Increased hippocampal noadrenaline is a biomarker for efficacyof vagus nerve stimulation in a limbic seizure model. J Neurochem, 2011, 117, 461-469.
32. Senard JM, Brefel-Courbon C, Rascol O, Montrastuc JL: Orthostatic hypotension in patients with Parkinson's disease: Pathophysiology and management. Drugs Aging, 2001, 18, 495-505. (Pubitemid 32664724)
33. Singer C, Weiner WJ, Sanchez-Ramos JR: Autonomic dysfunction in men with Parkinson's disease. Eur Neurol, 1992, 32, 134-140.
34. Weiner WJ: Early diagnosis of Parkinson's disease and initiation of treatment. Rev Neurol Dis, 2008, 5, 46-53.
35. Woodbury DM, Woodbury JW: Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia, 1990, 31, Suppl 2, S7-19.
36. Wu JJ, Shih CJ, Lin MT: Tachycardia, hypertension and decreased reflex bradycardia produced by striatal lesions induced by kainic acid. Neuropharmacology, 1984, 23, 228-233.
37. Zaraska K, Ziomber A, Ciesielczyk K, Bugajski A, Wioeniewska O, Skowron B, Juszczak K et al.: Electric activity of vagus nerve in rats according to satiety (Polish). Folia Medica Cracoviensia, 2011, 51, 5-17.
38. Ziomber A, Juszczak K, Kaszuba-Zwoinska J, Machowska A, Zaraska K, Gil K, Thor P: Magnetically induced vagus nerve stimulation and feeding behavior in rats. J Physiol Pharmacol, 2009, 60, 71-77.